ERBB2 and breast cancer: Previous studies have shown that the scheme used in patients with HER-2-positive BC was 8 mg/Kg with a loading dose and a standard maintenance dose of 6 mg/Kg for one year, with a total of 17–18 cycles, respectively [26,27,28].